These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29019676)

  • 21. Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex.
    Salemi LM; Maitland MER; Yefet ER; Schild-Poulter C
    BMC Cancer; 2017 Jul; 17(1):460. PubMed ID: 28668087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the discovery of potent and selective HDAC6 inhibitors.
    Wang XX; Wan RZ; Liu ZP
    Eur J Med Chem; 2018 Jan; 143():1406-1418. PubMed ID: 29133060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition.
    Kalveram B; Schmidtke G; Groettrup M
    J Cell Sci; 2008 Dec; 121(Pt 24):4079-88. PubMed ID: 19033385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The zinc finger of NEMO is a functional ubiquitin-binding domain.
    Cordier F; Grubisha O; Traincard F; Véron M; Delepierre M; Agou F
    J Biol Chem; 2009 Jan; 284(5):2902-2907. PubMed ID: 19033441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of HDAC6 increases acetylation of peroxiredoxin1/2 and ameliorates 6-OHDA induced dopaminergic injury.
    Jian W; Wei X; Chen L; Wang Z; Sun Y; Zhu S; Lou H; Yan S; Li X; Zhou J; Zhang B
    Neurosci Lett; 2017 Sep; 658():114-120. PubMed ID: 28823893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors.
    Leonhardt M; Sellmer A; Krämer OH; Dove S; Elz S; Kraus B; Beyer M; Mahboobi S
    Eur J Med Chem; 2018 May; 152():329-357. PubMed ID: 29738953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicomponent Synthesis and Binding Mode of Imidazo[1,2- a]pyridine-Capped Selective HDAC6 Inhibitors.
    Mackwitz MKW; Hamacher A; Osko JD; Held J; Schöler A; Christianson DW; Kassack MU; Hansen FK
    Org Lett; 2018 Jun; 20(11):3255-3258. PubMed ID: 29790770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of HDAC6 activity in kidney diseases: a new perspective.
    Ke B; Chen Y; Tu W; Ye T; Fang X; Yang L
    Mol Med; 2018 Jun; 24(1):33. PubMed ID: 30134806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insight into the zinc finger CW domain as a histone modification reader.
    He F; Umehara T; Saito K; Harada T; Watanabe S; Yabuki T; Kigawa T; Takahashi M; Kuwasako K; Tsuda K; Matsuda T; Aoki M; Seki E; Kobayashi N; Güntert P; Yokoyama S; Muto Y
    Structure; 2010 Sep; 18(9):1127-39. PubMed ID: 20826339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes.
    Hook SS; Orian A; Cowley SM; Eisenman RN
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13425-30. PubMed ID: 12354939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc finger protein binding to DNA: an energy perspective using molecular dynamics simulation and free energy calculations on mutants of both zinc finger domains and their specific DNA bases.
    Hamed MY; Arya G
    J Biomol Struct Dyn; 2016 May; 34(5):919-34. PubMed ID: 26196228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HDAC complex and cytoskeleton.
    Kovacs JJ; Hubbert C; Yao TP
    Novartis Found Symp; 2004; 259():170-7; discussion 178-81, 223-5. PubMed ID: 15171253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel mode of ubiquitin recognition by the ubiquitin-binding zinc finger domain of WRNIP1.
    Suzuki N; Rohaim A; Kato R; Dikic I; Wakatsuki S; Kawasaki M
    FEBS J; 2016 Jun; 283(11):2004-17. PubMed ID: 27062441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDAC6 and Ubp-M BUZ domains recognize specific C-terminal sequences of proteins.
    Hard RL; Liu J; Shen J; Zhou P; Pei D
    Biochemistry; 2010 Dec; 49(50):10737-46. PubMed ID: 21090589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for ubiquitin recognition by ubiquitin-binding zinc finger of FAAP20.
    Toma A; Takahashi TS; Sato Y; Yamagata A; Goto-Ito S; Nakada S; Fukuto A; Horikoshi Y; Tashiro S; Fukai S
    PLoS One; 2015; 10(3):e0120887. PubMed ID: 25799058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PIAS1 interacts with the KRAB zinc finger protein, ZNF133, via zinc finger motifs and regulates its transcriptional activity.
    Lee SJ; Lee JR; Hahn HS; Kim YH; Ahn JH; Bae CD; Yang JM; Hahn MJ
    Exp Mol Med; 2007 Aug; 39(4):450-7. PubMed ID: 17934332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin and its binding domains.
    Randles L; Walters KJ
    Front Biosci (Landmark Ed); 2012 Jun; 17(6):2140-57. PubMed ID: 22652769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective Inhibitors.
    Goracci L; Deschamps N; Randazzo GM; Petit C; Dos Santos Passos C; Carrupt PA; Simões-Pires C; Nurisso A
    Sci Rep; 2016 Jul; 6():29086. PubMed ID: 27404291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A C2HC zinc finger is essential for the RING-E2 interaction of the ubiquitin ligase RNF125.
    Bijlmakers MJ; Teixeira JM; Boer R; Mayzel M; Puig-Sàrries P; Karlsson G; Coll M; Pons M; Crosas B
    Sci Rep; 2016 Jul; 6():29232. PubMed ID: 27411375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.